Ingen Technologies Inc
OTC:IGNT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Ingen Technologies Inc
OTC:IGNT
|
89.6 USD | -0.1 | 0 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
165.7B USD | 64.1 | 58 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
163B USD | 22.2 | 26 | |
| US |
|
Stryker Corp
NYSE:SYK
|
122.9B USD | 31.3 | 37.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
105.1B USD | 23 | 22.8 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
86.7B USD | 26.2 | 24.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.8B USD | 33.1 | 43.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
39.8B EUR | 21.1 | 18.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.3B USD | 43.7 | 42.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
42.6B USD | 22.3 | 24.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
31.6B USD | 17.2 | 21.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 15.4 |
| Median | 23.2 |
| 70th Percentile | 35.1 |
| Max | 3 178 983.5 |
Other Multiples
Ingen Technologies Inc
Glance View
Ingen Technologies, Inc. engages in the manufacture of respiratory medical devices. The company is headquartered in Riverside, California. The company went IPO on 2001-07-11. The firm through its subsidiary, Ingen Technologies, Inc., is engaged in medical device manufacturing. The firm manufactures medical equipment for patients suffering with chronic obstructive pulmonary disease (COPD) and requiring oxygen therapy through home healthcare, hospitals, military and government-based medical facilities. The firm manufactures oxygen flow meters and nasal cannulas under Oxyview and Smart Nasal Cannula names. The firm offers both a reusable Oxyview and a disposable Smart Nasal Cannula with Oxyview attached to a nasal cannula. Oxyview is a pneumatic oxygen in-line flow meter. The Smart Nasal Cannula with Oxyview is a disposable nasal cannula that includes the Oxyview assembled and in-line. Oxyview is manufactured in two models: model 206A and model 203A. The Smart Nasal Cannula is available in six models: models 203NCA, 206NCA, 203NCP, 206NCP, 203NCI and 206NCI.
